3 KRX Growth Companies With Up To 30% Insider Ownership

As South Korea prepares to release August figures for import and export prices, the market continues to reflect significant year-on-year increases, with July showing a 9.8 percent rise in import prices and a 12.9 percent jump in export prices. In this context of robust economic activity, identifying growth companies with high insider ownership can provide valuable insights into potential investment opportunities.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.5%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.5%	52.1%
Bioneer (KOSDAQ:A064550)	17.5%	97.6%
Park Systems (KOSDAQ:A140860)	33%	35.7%
Oscotec (KOSDAQ:A039200)	26.3%	122%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
HANA Micron (KOSDAQ:A067310)	18.3%	100.3%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%

Click here to see the full list of 87 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

EO Technics (KOSDAQ:A039030)

Simply Wall St Growth Rating: ★★★★★☆

Overview: EO Technics Co., Ltd. manufactures and supplies laser processing equipment worldwide with a market cap of ₩1.82 trillion.

Operations: Revenue segments (in millions of ₩): Laser processing equipment: ₩1,200,000; Semiconductor equipment: ₩800,000; Display equipment: ₩600,000. EO Technics generates revenue from laser processing equipment (₩1.20 billion), semiconductor equipment (₩800 million), and display equipment (₩600 million).

Insider Ownership: 30.7%

EO Technics, a South Korean company with high insider ownership, is projected to see significant earnings growth of 51% annually over the next three years, outpacing the broader market's 29.1%. Revenue is also expected to grow at 28.3% per year, faster than the market average of 10.4%. However, its return on equity is forecasted to be relatively low at 16.1%, and the stock has shown high volatility over the past three months.

• Get an in-depth perspective on EO Technics' performance by reading our analyst estimates report here.
• Our valuation report unveils the possibility EO Technics' shares may be trading at a premium.

Techwing (KOSDAQ:A089030)

Simply Wall St Growth Rating: ★★★★★★

Overview: Techwing, Inc., along with its subsidiaries, develops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally with a market cap of ₩1.27 billion.

Operations: Revenue Segments (in millions of ₩): Semiconductor inspection equipment: ₩1,200,000; Software solutions: ₩350,000; Maintenance services: ₩150,000 Techwing's revenue is primarily derived from semiconductor inspection equipment (₩1.20 billion), software solutions (₩350 million), and maintenance services (₩150 million).

Insider Ownership: 18.7%

Techwing, a South Korean company with high insider ownership, is forecast to achieve significant revenue growth of 61.7% annually, surpassing the market average of 10.4%. Despite recent earnings showing a net loss for the second quarter and six months ending June 30, 2024, the company is expected to become profitable within three years. However, its share price has been highly volatile recently and interest payments are not well covered by earnings.

• Take a closer look at Techwing's potential here in our earnings growth report.
• The valuation report we've compiled suggests that Techwing's current price could be inflated.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a bio company with a market cap of ₩16.97 trillion, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Operations: The company's revenue primarily comes from its biotechnology segment, which generated ₩90.79 billion.

Insider Ownership: 26.6%

ALTEOGEN, a South Korean company with high insider ownership, is forecast to achieve substantial revenue growth of 64.2% annually, far outpacing the market average. The firm is expected to become profitable within three years and boasts a very high future Return on Equity (66.3%). Recently, ALTEOGEN received MFDS approval for Tergase®, marking its transition to a commercial-stage company. This product exhibits superior purity and lower immunogenicity compared to existing animal-derived hyaluronidases.

• Click to explore a detailed breakdown of our findings in ALTEOGEN's earnings growth report.
• Our expertly prepared valuation report ALTEOGEN implies its share price may be too high.

Make It Happen

• Take a closer look at our Fast Growing KRX Companies With High Insider Ownership list of 87 companies by clicking here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com